This is the authors' abstract. We don't add key points for this paper.
Background Pregnancy in women with a history of cancer or a new cancer diagnosis presents challenges for both oncological treatment and obstetric management. This study aimed to compare maternal, obstetric, and neonatal outcomes between cancer survivors and women diagnosed with cancer during pregnancy. Methods This retrospective single-center study included 36 women with cancer who were managed at a tertiary perinatology center between 2018 and 2025. Twenty-four patients had been diagnosed and treated before pregnancy, while 12 were diagnosed during pregnancy. Clinical characteristics, cancer types, treatment modalities, pregnancy complications, and fetal and neonatal outcomes were obtained from medical records. Continuous variables were compared using the independent-samples t-test and categorical variables using the Pearson chi-square test. A p value < 0.05 was considered statistically significant. Results Maternal age was similar between cancer survivors and women diagnosed during pregnancy (35 ± 5 vs. 35 ± 6 years, p = 0.90). Maternal complications did not differ significantly between the groups (20.8% vs. 16.7%, p = 0.766). Cesarean delivery was the predominant mode of delivery (75.0% vs. 60.0%, p = 0.420). After excluding pregnancy terminations, delivery before 34 weeks occurred in 12.5% of cancer survivors and 8.3% of women diagnosed during pregnancy. Mean birth weight was 3166 ± 591 g and 2784 ± 562 g, respectively (p = 0.15). Neonatal intensive care unit admission rates were similar (26.7% vs. 27.3%), while the 5-minute Apgar score was significantly lower among infants born to cancer survivors (8 vs. 9, p < 0.001). Conclusions Maternal and neonatal outcomes were generally favorable in both cancer survivors and women diagnosed with cancer during pregnancy. Similar rates of maternal complications, early preterm delivery, and neonatal intensive care unit admission suggest that favorable pregnancy outcomes can be achieved with individualized multidisciplinary management. Avoiding unnecessary early delivery when maternal condition and cancer treatment allow may further improve neonatal outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kul et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: